185
Views
3
CrossRef citations to date
0
Altmetric
Articles

Lowe syndrome with extremely short stature: growth hormone deficiency may be the pathogeny

, , , , , , & show all
Pages 170-177 | Received 03 Jun 2019, Accepted 28 Aug 2019, Published online: 02 Oct 2019

References

  • Abdalla, E., A. El-Beheiry, K. Dieterich, J. Thevenon, J. Faure, and J. Rendu. 2018. “Lowe Syndrome: A Particularly Severe Phenotype without Clinical Kidney Involvement.” American Journal of Medical Genetics Part A 176 (2): 460–464.
  • Bittner, M. A., and R. W. Holz. 2005. “Phosphatidylinositol-4,5-Bisphosphate: Actin Dynamics and the Regulation of ATP-Dependent and -Independent Secretion.” Molecular Pharmacology 67 (4): 1089–1098.
  • Bockenhauer, D., A. Bokenkamp, W. van’t Hoff, E. Levtchenko, J. E. Kist-van Holthe, V. Tasic, and M. Ludwig. 2008. “Renal Phenotype in Lowe Syndrome: A Selective Proximal Tubular Dysfunction.” Clinical Journal of the American Society of Nephrology 3 (5): 1430–1436.
  • Bokenkamp, A., and M. Ludwig. 2016. “The Oculocerebrorenal Syndrome of Lowe: An Update.” Pediatric Nephrology 31 (12): 2201–2212.
  • Charnas, L. R., I. Bernardini, D. Rader, J. M. Hoeg, and W. A. Gahl. 1991. “Clinical and Laboratory Findings in the Oculocerebrorenal Syndrome of Lowe, with Special Reference to Growth and Renal Function.” New England Journal of Medicine 324 (19): 1318–1325.
  • Christine, K. 2010. “Living with Lowe's Syndrome. A Guide for Families, Friends, and Professionals.” In Living with Lowe Syndrome: A Guide for Families Living with Lowe Syndrome: A Guide for Families and Professionals, 4th ed., part III, 33–35.
  • Cui, S., C. J. Guerriero, C. M. Szalinski, C. L. Kinlough, R. P. Hughey, and O. A. Weisz. 2010. “OCRL1 Function in Renal Epithelial Membrane Traffic.” American Journal of Physiology-Renal Physiology 298 (2): F335–F345.
  • Festa, B. P., M. Berquez, A. Gassama, I. Amrein, H. M. Ismail, M. Samardzija, L. Staiano, et al. 2018. “OCRL Deficiency Impairs Endolysosomal Function in a Humanized Mouse Model for Lowe Syndrome and Dent Disease.” Human Molecular Genetics 28: 1931–1946.
  • Galvez-Ruiz, A., A. Galindo-Ferreiro, and H. Alkatan. 2018. “A Clinical Case of Zellweger Syndrome in a Patient with a Previous History of Ocular Medulloepithelioma.” Saudi Journal of Ophthalmology 32 (3): 241–245.
  • Gupta, A., D. M. Bhowmik, A. Khaira, B. Singh, and S. C. Tiwari. 2010. “Dent’s Disease and Lowe’s Syndrome: A Phenotypic Spectrum of One Gene.” Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia 21 (1): 155–156.
  • Hou, J. W. 2009. “Amelioration of Hypophosphatemic Rickets and Osteoporosis with Pamidronate and Growth Hormone in Lowe Syndrome.” Journal of the Formosan Medical Association 108 (9): 730–735.
  • Kim, H. K., J. H. Kim, Y. M. Kim, G. H. Kim, B. H. Lee, J. H. Choi, and H. W. Yoo. 2014. “Lowe Syndrome: A Single Center’s Experience in Korea.” Korean Journal of Pediatrics 57 (3): 140–148.
  • Loi, M. 2006. “Lowe Syndrome.” Orphanet Journal of Rare Diseases 1 (1): 16. doi:10.1186/1750-1172-1-16.
  • Lowe, C. U., M. Terrey, and L. E. Mac. 1952. “Organic-Aciduria, Decreased Renal Ammonia Production, Hydrophthalmos, and Mental Retardation; a Clinical Entity.” Archives of Pediatrics & Adolescent Medicine 83 (2): 164–184. doi:10.1001/archpedi.1952.02040060030004.
  • Maia, M. L., M. L. do Val, C. P. Genzani, F. A. Fernandes, M. C. de Andrade, and J. T. Carvalhaes. 2010. “Lowe Syndrome: Report of Five cases.” Journal Brasileiro de Nefrologia: ‘Orgao Oficial de Sociedades Brasileira e Latino-Americana de Nefrologia 32 (2): 216–222.
  • Ramos, A. R., S. Ghosh, and C. Erneux. 2019. “The Impact of PI 5-Phosphatases on Phosphoinositides in Cell Function and Human Disease.” Journal of Lipid Research 60: 276–286. doi:10.1194/jlr.R087908ERR.
  • Recker, F., H. Reutter, and M. Ludwig. 2013. “Lowe Syndrome/Dent-2 Disease: A Comprehensive Review of Known and Novel Aspects.” Journal of Pediatric Genetics 02 (02): 053–068.
  • Silver, D. N., R. A. Lewis, and R. L. Nussbaum. 1987. “Mapping the Lowe Oculocerebrorenal Syndrome to Xq24-q26 by Use of Restriction Fragment Length Polymorphisms.” Journal of Clinical Investigation 79 (1): 282–285. doi:10.1172/JCI112795.
  • Sugimoto, K., H. Nishi, T. Miyazawa, S. Fujita, M. Okada, and T. Takemura. 2014. “A Novel OCRL1 Mutation in a Patient with the Mild Phenotype of Lowe Syndrome.” The Tohoku Journal of Experimental Medicine 232 (3): 163–166. doi:10.1620/tjem.232.163.
  • Warner, B. E., C. D. Inward, and C. P. J. Burren. 2017. “Gonadotrophin Abnormalities in an Infant with Lowe Syndrome.” Endocrinology, Diabetes & Metabolism Case Reports. 2017 (1). doi:10.1530/EDM-17-0042.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.